Neurophysiological basis of rapid eye movement sleep behavior disorder: Informing future drug development
Publikation: Bidrag til tidsskrift › Review › fagfællebedømt
Standard
Neurophysiological basis of rapid eye movement sleep behavior disorder : Informing future drug development. / Jennum, Poul; Christensen, Julie Anja Engelhard; Zoetmulder, Marielle.
I: Nature and Science of Sleep, Bind 8, 2016, s. 107-120.Publikation: Bidrag til tidsskrift › Review › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Neurophysiological basis of rapid eye movement sleep behavior disorder
T2 - Informing future drug development
AU - Jennum, Poul
AU - Christensen, Julie Anja Engelhard
AU - Zoetmulder, Marielle
PY - 2016
Y1 - 2016
N2 - Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by a history of recurrent nocturnal dream enactment behavior and loss of skeletal muscle atonia and increased phasic muscle activity during REM sleep: REM sleep without atonia. RBD and associated comorbidities have recently been identified as one of the most specific and potentially sensitive risk factors for later development of any of the alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and other atypical parkinsonian syndromes. Several other sleep-related abnormalities have recently been identified in patients with RBD/Parkinson's disease who experience abnormalities in sleep electroencephalographic frequencies, sleep-wake transitions, wake and sleep stability, occurrence and morphology of sleep spindles, and electrooculography measures. These findings suggest a gradual involvement of the brainstem and other structures, which is in line with the gradual involvement known in these disorders. We propose that these findings may help identify biomarkers of individuals at high risk of subsequent conversion to parkinsonism.
AB - Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by a history of recurrent nocturnal dream enactment behavior and loss of skeletal muscle atonia and increased phasic muscle activity during REM sleep: REM sleep without atonia. RBD and associated comorbidities have recently been identified as one of the most specific and potentially sensitive risk factors for later development of any of the alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and other atypical parkinsonian syndromes. Several other sleep-related abnormalities have recently been identified in patients with RBD/Parkinson's disease who experience abnormalities in sleep electroencephalographic frequencies, sleep-wake transitions, wake and sleep stability, occurrence and morphology of sleep spindles, and electrooculography measures. These findings suggest a gradual involvement of the brainstem and other structures, which is in line with the gradual involvement known in these disorders. We propose that these findings may help identify biomarkers of individuals at high risk of subsequent conversion to parkinsonism.
KW - Brain stem
KW - Hypocretin
KW - Hypothalamus
KW - Motor control
U2 - 10.2147/NSS.S99240
DO - 10.2147/NSS.S99240
M3 - Review
C2 - 27186147
AN - SCOPUS:84979582232
VL - 8
SP - 107
EP - 120
JO - Nature and Science of Sleep
JF - Nature and Science of Sleep
SN - 1179-1608
ER -
ID: 179174407